EC Number |
Activating Compound |
Reference |
---|
2.7.1.67 | 2-mercaptoethanol |
enhances activity |
641770 |
2.7.1.67 | 2-[[(2-methoxyphenyl)methyl]amino]-2-oxoethyl 2-(furan-2-yl)quinoline-4-carboxylate |
- |
759590 |
2.7.1.67 | 25-hydroxycholesterol |
activates Golgi/endosome-associated PI4K activity, PI4K activation by 25-hydroxycholesterol is dependent on oxysterol binding protein, overview |
723136 |
2.7.1.67 | 3-Mercaptopropionic acid |
enhances activity |
641770 |
2.7.1.67 | 4-[4-[(2-oxo-2,3-dihydro-1H-indol-5-yl)sulfonyl]piperazin-1-yl]benzaldehyde |
- |
759590 |
2.7.1.67 | 4-[9-(3,4-dimethoxyphenyl)-2-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purin-8-yl]benzaldehyde |
138% residual activity at 0.01 mM |
758912 |
2.7.1.67 | 4-[9-(3,4-dimethoxyphenyl)-2-methyl-6-[[2-(morpholin-4-yl)ethyl]amino]-9H-purin-8-yl]phenol |
125% residual activity at 0.01 mM |
758912 |
2.7.1.67 | 9-(3,4-dimethoxyphenyl)-2,8-dimethyl-N-[2-(morpholin-4-yl)ethyl]-9H-purin-6-amine |
126% residual activity at 0.01 mM |
758912 |
2.7.1.67 | 9-(3,4-dimethoxyphenyl)-2-methyl-N-[2-(morpholin-4-yl)ethyl]-8-(4-phenoxyphenyl)-9H-purin-6-amine |
112% activity at 0.01 mM |
758912 |
2.7.1.67 | amyloid beta31-34 |
fragment of amyloid beta, blocks amyloid beta1-42-induced inhibition of type II phosphatidylinositol 4-kinase activity |
694380 |